| PRD_000246 | Name: | N~2~-acetyl-N~5~-[amino(iminio)methyl]-L-ornithyl-L-alpha-glutamyl-N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-N~5~-
[amino(iminio)methyl]-L-ornithinamide | Formula: | C26 H52 Cl N11 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000247 | Name: | N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-L-leucyl-L-phenylalaninamide | Formula: | C23 H36 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000249 | Name: | N~1~-(3-aminobenzyl)-N~2~-[(2R)-2-(hydroxycarbamoyl)-4-methylpentanoyl]-L-aspartamide | Formula: | C18 H27 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000250 | Name: | N-acetyl-L-valyl-O-benzyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-{[(3R)-2-oxopyrrolidin-3-yl]methyl}propyl]-L-leucinamide | Formula: | C32 H51 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000252 | Name: | Ac-Tyr-Val-Ala-Asp-Aldehyde | Formula: | C23 H32 N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000253 | Name: | amino{[(4S)-4-{[(benzyloxy)carbonyl]amino}-5-{[(2S)-1-(benzyloxy)-4-chloro-3-oxobutan-2-yl]amino}-5-oxopentyl]amino}met
haniminium | Formula: | C25 H33 Cl N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000254 | Name: | methyl N-(4-carbamimidamidobutanoyl)-L-phenylalanyl-L-allothreonyl-L-phenylalaninate | Formula: | C28 H38 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000256 | Name: | benzyl [(1R,4S,6S,9R)-4,6-dibenzyl-5-hydroxy-1,9-bis(1-methylethyl)-2,8,11-trioxo-13-phenyl-12-oxa-3,7,10-triazatridec-1-yl]carbamate | Formula: | C43 H52 N4 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000257 | Name: | N-{(2S)-2-[(N-acetyl-4-carbamimidoyl-L-phenylalanyl)amino]-2-cyclohexylacetyl}-3-(1-methylpyridinium-3-yl)-
L-alanyl-D-leucyl-L-prolinamide | Formula: | C40 H58 N9 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000258 | Name: | N-[(1S)-3-{[(benzyloxy)carbonyl]amino}-1-carboxypropyl]-L-leucyl-N-(2-morpholin-4-ylethyl)-L-phenylalaninamide | Formula: | C33 H47 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000259 | Name: | N-acetyl-L-tryptophyl-L-alpha-glutamyl-N-[(1R)-2-carboxy-1-formylethyl]-3-(1H-imidazol-3-ium-4-yl)-L-alaninamide | Formula: | C28 H36 N7 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000260 | Name: | N-(tert-butoxycarbonyl)-L-alanyl-N-[(1R)-1-(carboxyamino)-2-phenylethyl]-L-prolinamide | Formula: | C22 H32 N4 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000261 | Name: | N-(tert-butoxycarbonyl)-L-alanyl-N-[(1R)-1-(dihydroxyboranyl)-2-methylpropyl]-L-prolinamide | Formula: | C17 H32 B N3 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000262 | Name: | 6-ammonio-N-{[(2R,3R)-3-{[N-(tert-butoxycarbonyl)-L-phenylalanyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl]amino}-4-cyclohexyl-2-hydroxybutyl](2-methylpropyl)carbamoyl}-L-norleucyl-L-phenylalanine | Formula: | C50 H77 N9 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000263 | Name: | 6-ammonio-N-[(2R,4R,5R)-5-{[N-(tert-butoxycarbonyl)-L-phenylalanyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl]amino}-6-cyclohexyl-4-hydroxy-2-(2-methylpropyl)hexanoyl]-L-norleucylphenylalanine | Formula: | C51 H78 N8 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000264 | Name: | N-(tert-butoxycarbonyl)-L-phenylalanyl-N-{(1S)-1-[(R)-hydroxy(2-{[(2S)-2-methylbutyl]amino}-2-oxoethyl)phosphoryl]-3-methylbutyl}-3-(1H-imidazol-3-ium-4-yl)-L-alaninamide | Formula: | C32 H52 N6 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000265 | Name: | (2S)-2-[[(3S,4S)-5-cyclohexyl-4-[[(4S,5S)-5-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxidanyl-6-phenyl-hexanoyl]amino]
-3-oxidanyl-pentanoyl]amino]-4-methyl-pentanoic acid | Formula: | C34 H55 N3 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000266 | Formula: | C52 H81 N11 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000267 | Name: | H-261 Oligopeptide | Formula: | C55 H84 N13 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000268 | Name: | L-364,099 | Formula: | C54 H77 N11 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000269 | Name: | [1-BENZYL-3-(8-SEC-BUTYL-7,10-DIOXO-2-OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA-1(16),13(17),14-TRIEN-11-YLAMINO)-2-HYDROXY-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER | Formula: | C33 H48 N4 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000270 | Name: | 4-biphenylacetyl-CYS-(D)ARG-TYR-N-(2-phenylethyl) amide | Formula: | C40 H49 N7 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000271 | Name: | N-[(benzyloxy)carbonyl]-L-isoleucyl-N-[(1R)-1-(carboxycarbonyl)-3,3-difluoropropyl]-L-leucinamide | Formula: | C25 H35 F2 N3 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000272 | Name: | CBZ-DEHYDRO-LEU-VAL-ARG-TYR | Formula: | C34 H50 N7 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000275 | Name: | Ac-DADE-F(2)Pmp-L-NH(2) | Formula: | C32 H46 F2 N7 O15 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|